Irani Mohamad, Merhi Zaher
Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont College of Medicine, Burlington, Vermont.
Fertil Steril. 2014 Aug;102(2):460-468.e3. doi: 10.1016/j.fertnstert.2014.04.046. Epub 2014 Jun 3.
To report an update on the role of vitamin D (VD) in ovarian physiology with a focus on genes involved in steroidogenesis, follicular development, and ovarian reserve, as well as ovulatory dysfunction associated with polycystic ovary syndrome (PCOS), and ovarian response to assisted reproductive technology (ART).
Systematic review.
Not applicable.
PATIENT(S): Human, animal, and cell culture models.
INTERVENTION(S): Pubmed literature search.
MAIN OUTCOME MEASURE(S): Granulosa cell function, serum antimüllerian hormone (AMH), AMH and its receptor gene expression, soluble receptor for advanced glycation end-products (sRAGE), PCOS parameters, and ART outcome.
RESULT(S): In human granulosa cells, VD alters AMH signaling, FSH sensitivity, and progesterone production and release, indicating a possible physiologic role for VD in ovarian follicular development and luteinization. In the serum, 25-hydroxyvitamin D (25OH-D) is positively correlated with AMH, and appropriate VD supplementation in VD-depleted women can suppress the seasonal changes that occur in serum AMH. In VD-deficient women with PCOS, VD supplementation lowers the abnormally elevated serum AMH levels, possibly indicating a mechanism by which VD improves folliculogenesis. The antiinflammatory sRAGE serum levels significantly increase in women with PCOS after VD replacement. Although follicular fluid 25OH-D correlates with IVF outcomes, there is a lack of data pertaining to the impact of VD supplementation on pregnancy rates following IVF.
CONCLUSION(S): This review underscores the need for understanding the mechanistic actions of VD in ovarian physiology and the critical need for randomized trials to elucidate the impact of VD supplementation on controlled ovarian hyperstimulation/IVF outcome and ovulatory dysfunction associated with PCOS.
报告维生素D(VD)在卵巢生理中的作用的最新进展,重点关注参与类固醇生成、卵泡发育和卵巢储备的基因,以及与多囊卵巢综合征(PCOS)相关的排卵功能障碍和卵巢对辅助生殖技术(ART)的反应。
系统评价。
不适用。
人类、动物和细胞培养模型。
PubMed文献检索。
颗粒细胞功能、血清抗苗勒管激素(AMH)、AMH及其受体基因表达、晚期糖基化终产物可溶性受体(sRAGE)、PCOS参数和ART结局。
在人类颗粒细胞中,VD改变AMH信号传导、FSH敏感性以及孕酮的产生和释放,表明VD在卵巢卵泡发育和黄体化中可能具有生理作用。在血清中,25-羟维生素D(25OH-D)与AMH呈正相关,对VD缺乏的女性进行适当的VD补充可抑制血清AMH中出现的季节性变化。在患有PCOS的VD缺乏女性中,补充VD可降低异常升高的血清AMH水平,这可能表明VD改善卵泡生成的一种机制。VD替代后,PCOS女性的抗炎性sRAGE血清水平显著升高。虽然卵泡液25OH-D与IVF结局相关,但缺乏关于补充VD对IVF后妊娠率影响的数据。
本综述强调了理解VD在卵巢生理中的作用机制的必要性,以及进行随机试验以阐明补充VD对控制性卵巢过度刺激/IVF结局和与PCOS相关的排卵功能障碍的影响的迫切需求。